Compass Therapeutics, Inc.
Ticker: 1738021
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY2024 | Q2 FY2024 |
|---|---|---|
| INCOME | ||
| Revenue | 0.85+0.0% | 0.85 |
| Total Income | 0.85+0.0% | 0.85 |
| EXPENSES | ||
| Expenditure | 15.90+0.0% | 15.90 |
| Tax | — | 0.00 |
| PROFIT | ||
| PBT | — | -13.08 |
| Net Profit | -13.08+0.0% | -13.08 |
| KEY METRICS | ||
| OPM % | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% |
| EPS | -0.10+0.0% | -0.10 |
Corporate Events
Board MeetingCMPX
202610Jun
Board Meeting
Annual Meeting of Stockholders held to elect two Class III d…
SEC Filing ↗